Biaryl PDE4 inhibitors for treating inflammation

Details for Australian Patent Application No. 2008326381 (hide)

Owner deCODE genetics ehf

Inventors Motta, Adalie; Schultz, Gary; Burgin, Alex; Kiselyov, Alexander; Singh, Jasbir; Sandanayaka, Vincent; Hategan, Georgeta; Gurney, Mark E.; Hagen, Timothy

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008326381

PCT Pub. Number WO2009/067600

Priority 60/989,551 21.11.07 US

Filing date 20 November 2008

Wipo publication date 28 May 2009

International Classifications

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4439 (2006.01)

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 213/06 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/79 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/84 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/89 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 233/90 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 275/06 (2006.01) Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

C07D 285/135 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 473/18 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 473/40 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

15 July 2010 PCT application entered the National Phase

  PCT publication WO2009/067600 Priority application(s): WO2009/067600

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008326385-Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

2008326360-Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators